Advertisement
Advertisement

TECX

TECX logo

Tectonic Therapeutic Inc.

44.50
USD
-3.03
-6.38%
Dec 18, 14:38 UTC -5
Open

Tectonic Therapeutic Inc. Profile

About

Tectonic Therapeutic Inc. is a biotechnology company developing GPCR -targeted therapeutic proteins. Tectonic Therapeutic Inc., formerly known as AVROBIO Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Erik Ostrowski

Headquarters

100 TECHNOLOGY SQUARE, 6TH FLOOR
CAMBRIDGE, MA 02139, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

5

Employees

13

Tectonic Therapeutic Inc. Statistics

Valuation Measures

Market Capitalization2

656.38M

Enterprise Value

498.27M

Enterprise Value/EBITDA(ttm)

29.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.44

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-35.53%

Return on Invested Capital(ttm)

-95.79%

Return on Assets(ttm)

-31.97%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

17.09M

Net Income Available to Common(ttm)

20.43M

Diluted EPS(ttm)

-5.89

Share Statistics

Beta (5Y Monthly)

2.60

52-Week Change

180.93%

S&P 500 52-Week Change

26.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.75M

Dividend Yield

0.00%

Float4

13.40M

% Held by Insiders

9.20%

% Held by Institutions

62.63%

Balance Sheet

Total Cash(mrq)

159.09M

Total Cash Per Share(mrq)

10.78

Total Debt(mrq)

991.00K

Total Debt/Equity(mrq)

0.66%

Current Ratio(mrq)

9.39%

Quick Ratio(mrq)

9.39%

Book Value Per Share(mrq)

10.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.87

Free Cash Flow(ytd)

-42.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement